Xi Liu
Founder bei BEIJING STRONG BIOTECHNOLOGIES,INC.
Vermögen: 179 Mio $ am 31.03.2024
Profil
Xi Liu founded Beijing Strong Biotechnologies, Inc. in 2001, where he is working as General Manager & Director from 2011.
Dr. Liu also currently works at Fuzhou Maixin Biotech Co., Ltd., as Director from 2020.
Dr. Liu received his graduate degree in 1982 from Harbin Engineering University and doctorate degree in 1988 from Institute of Automation Chinese Academy of Sciences.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
30.06.2023 | 50 260 257 ( 19,76% ) | 134 Mio $ | 31.03.2024 | |
30.06.2023 | 16 753 419 ( 5,01% ) | 45 Mio $ | 31.03.2024 |
Aktive Positionen von Xi Liu
Unternehmen | Position | Beginn |
---|---|---|
BEIJING STRONG BIOTECHNOLOGIES,INC. | Founder | 29.03.2001 |
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Director/Board Member | 30.09.2020 |
Ausbildung von Xi Liu
Harbin Engineering University | Graduate Degree |
Institute of Automation Chinese Academy of Sciences | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The private company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |